ArticleAmerican journal of hematology2012

Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.

Vijay Ramakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.